medigraphic.com
ISSN 1561-3119 (Electronic)

2019, Number 4

<< Back

Rev Cubana Pediatr 2019; 91 (4)

Mycoplasma Pneumoniae, associated to autoimmune axonal polyneuropathy, clinical variant of Guillain-Barré Syndrome in children?

Zemelman MC, Petermann TA, Petermann TD

Language: Spanish
References: 21
Page: 1-11
PDF size: 270.14 Kb.


ABSTRACT

Introduction: Mycoplasma pneumoniae is a pathogen know as to the main causal agent of atypical pneumonia, as well as to generate different extrapulmonary sickness, especially in neurological ways, directing to the nervous system, thanks to all its different mechanisms, like: virulence, mimetysm and immunomodulation in to the host. Producing, pathologies like neuropathies, polyneuropathies, encephalopathies, Guillain Barré Syndrome.
Objetives: To highlight in the pediatric area, the need to modificate diagnosis criteria and incorporate Guillain-Barre Syndrome clinicals variants, also instruments to diagnosis of neuropathic pathologies.
Case presentation: Male patient, 9 years, 8 months old, who consulted in repeated occasions for: dyspepsia, diarrhea and constipation episodes and fiber. Confirmed according to consultation: dysbiosis, common cold, and finally, atypical pneumonia by Mycoplasma Pneumoniae. The patient evolves with: muscular weakness, hyperalgesia and allodynia of upper and inferior extremities. Then, the Neurologist, indicates neurophysiological exams (nerve conduction velocity, evoked potentials, discarding an electromyography, due to hyperalgesia). Diagnosing an axonal polyneuropathy. Which was characterized to present some same aspects, from clinical course of Guillain-Barre Syndrome. Highlighting that the clinical evolution, as also, the syndrome clinical variants, has it a course in adults, characterized by a different beginning and signs, than in children. Retarding and do a wrong diagnosis in pediatric patients.
Conclusion: Lack of new diagnosis criteria, the amplitude of these and tools of approach to give a fast and effective diagnosis, and contribute to the optimal recovery of the patient.


REFERENCES

  1. Merida-Vieyra J, Aquino-Andrade A, Ribas-Aparicio RM, De Colsa-Ranero A. Cambiando los paradigmas de la infección por M. pneumoniae en pediatría. Acta Pediatr Mex. 2017;38(6):412-26.

  2. Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 2008;3:635-48.

  3. Inostroza Pinto R. Neumonía por agentes atípicos en niños. Rev Clin Condes. 2017;28(1):90-6.

  4. Hopp E, Martínez L, Diaz M. Neumonía por Mycoplasma pneumoniae complicada con pancreatitis y hepatitis aguda: a propósito de un caso. Revista GEN. 2013;67(2):106-10.

  5. Waites K,Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697-728.

  6. Saraya T. Mycoplasma pneumoniae infection: Basics. J Gen Fam Med. 2017;18:118-25.

  7. Baharat B, Venkatram S, Díaz-Fuentes G. Mycoplasma pneumoniae: A Potencially Severe Infection. J Clin Med Res. 2018;10(7): 535-44.

  8. Mayo Foundation for Medical Education and Research: Mayo Clinic Staff (2017). The Foundation; ©1998-2018; actualizado 09/08/2017, acceso: 22/09/2018. Disponible en: https://www.mayoclinic.org/diseases-conditions/peripheral-neuropathy/symptoms-causes/syc-20352061

  9. Ortez C, Díaz A. Síndrome de Guillain-Barré en la infancia. An Pediatr Contin. 2013; 11(2):98-103.

  10. Kumar S. Mycoplasma pneumoniae: A significant but underrated pathogen in pediatric community-acquired lower respiratory tract infection. Indian J of Med Res. 2018;147(1):23-31.

  11. Parra M, Londoño L. Infección por Mycoplasma pneumoniae y polineuropatía periférica: Reporte de caso. Infectio. 2009;13(4):296-9.

  12. Peréz A, De Juan Frigola J. Protocolos de Neurología: Síndrome de Guillain -Barré. Bol Pediatr. 2006;46(1):49-55.

  13. Alcántara-Montiel JC, Vega-Torres BI. Síndrome hiper-IgE. Lecciones de la función y defectos de STAT-3 o DOCK-8. Rev Alerg Mex. 2016;63(4):385-96.

  14. Varela Rodríguez W. Síndrome de Guillain Barré atípico (Caso Clínico). Rev Méd Costa Rica Centroam. 2010;67(593):267-9.

  15. Martínez Roig A, Busquets Monge RM, López Segura N, Herrero Pérez S, Torné E. Coinfección por virus de Epstein-Barr y Mycoplasma pneumoniae en dos niñas con neumonía comunitaria. An Pediatr. 2002;56(1):69-70.

  16. Cruzado-Benites D, Ortiz-Cabrera J, Segura-Plasencia N, Cruzado-Ubillus W. Síndrome de Guillain -Barré: Un Caso Atípico. Rev Ecuat Neurol. 2016;25 (1-3):70-7.

  17. Yuki N, Kokubun N, Kuwabara S, Sekiguchi Y, Ito M, Odaka M. Guillain Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol.2012;259 (6): 1181-90.

  18. Erazo R. Síndrome Guillain Barre en Pediatría. Medicina (Buenos Aires). 2009;69 (1):84-91.

  19. Pier D, Hallbergson A, Peters J. Guillain-Barré syndrome in a child with pain: lessons learned from a late diagnosis. Acta Paediatr. 2010;99(10):1589-91.

  20. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, V van Doorn PA. Guillain-Barré syndrome: patohegenesis, diagnosis, treatment and prognosis. Nat Reviews Neurol. 2014;10(8):469-82. B Van Den Berg, C Walgaard, J Drenthen

  21. Alvarado J, Vergara L. Estudio electrodiagnóstico en Síndrome de Guillain Barré en adultos. Rev Chil Neuro-Psiquiatr. 2016;54(2):123-32.




2020     |     www.medigraphic.com